22 related articles for article (PubMed ID: 9169966)
1. Alprazolam and lorazepam overdose and the absence of brainstem reflexes.
Thumtecho S; Wainipitapong S; Chunamchai S; Suteparuk S
BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35537772
[TBL] [Abstract][Full Text] [Related]
2. The validation of a novel activity monitor in the measurement of posture and motion during everyday activities.
Grant PM; Ryan CG; Tigbe WW; Granat MH
Br J Sports Med; 2006 Dec; 40(12):992-7. PubMed ID: 16980531
[TBL] [Abstract][Full Text] [Related]
3. Ambulatory measurement of upper limb usage and mobility-related activities during normal daily life with an upper limb-activity monitor: a feasibility study.
Schasfoort FC; Bussmann JB; Stam HJ
Med Biol Eng Comput; 2002 Mar; 40(2):173-82. PubMed ID: 12043798
[TBL] [Abstract][Full Text] [Related]
4. Influence of patient's dressing on spontaneous physical activity and length of hospital stay in surgical patients.
Despond O; Buchser E; Sprunger AL; Sloutkis D
Soz Praventivmed; 1999; 44(1):8-13. PubMed ID: 10198952
[TBL] [Abstract][Full Text] [Related]
5. Quantification of physical activities by means of ambulatory accelerometry: a validation study.
Bussmann JB; Tulen JH; van Herel EC; Stam HJ
Psychophysiology; 1998 Sep; 35(5):488-96. PubMed ID: 9715093
[TBL] [Abstract][Full Text] [Related]
6. Effects of alprazolam and lorazepam on catecholaminergic and cardiovascular activity during supine rest, mental load and orthostatic challenge.
van den Berg F; Tulen JH; Boomsma F; Noten JB; Moleman P; Pepplinkhuizen L
Psychopharmacology (Berl); 1996 Nov; 128(1):21-30. PubMed ID: 8944402
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive indices of autonomic regulation after alprazolam and lorazepam: effects on sympathovagal balance.
Tulen JH; Man in't Veld AJ
J Cardiovasc Pharmacol; 1998 Aug; 32(2):183-90. PubMed ID: 9700978
[TBL] [Abstract][Full Text] [Related]
8. Effects of Oral Administration of Alprazolam and Lorazepam as Hypnotics on Cardiovascular Parameters in Hypertensive Patients.
Costa A; D'Angelo A; Ramusino MC; Perini G; Bosone D; Derosa G; Fogari R
J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):191-195. PubMed ID: 33587402
[TBL] [Abstract][Full Text] [Related]
9. A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam.
Busto UE; Kaplan HL; Wright CE; Gomez-Mancilla B; Zawertailo L; Greenblatt DJ; Sellers EM
J Clin Psychopharmacol; 2000 Dec; 20(6):628-35. PubMed ID: 11106134
[TBL] [Abstract][Full Text] [Related]
10. A novel tool to quantify physical activities: ambulatory accelerometry in psychopharmacology.
Tulen JH; Bussmann HB; van Steenis HG; Pepplinkhuizen L; Man in 't Veld AJ
J Clin Psychopharmacol; 1997 Jun; 17(3):202-7. PubMed ID: 9169966
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the abuse liability of alprazolam, lorazepam, diazepam, methaqualone, and placebo.
Orzack MH; Friedman L; Dessain E; Bird M; Beake B; McEachern J; Cole JO
Int J Addict; 1988 May; 23(5):449-67. PubMed ID: 3061941
[TBL] [Abstract][Full Text] [Related]
12. Review of the side-effect profile of buspirone.
Newton RE; Marunycz JD; Alderdice MT; Napoliello MJ
Am J Med; 1986 Mar; 80(3B):17-21. PubMed ID: 2870641
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
